Skip to content
zameds

Brimonidine (Agobrim W/v Eye)

Brimonidine

FDC SA (Pty) Ltd

S3Read from the PI-PIL document and verified

Registration

Applicant
FDC SA (Pty) Ltd
Certificate holder
FDC SA (Pty) Ltd
Registrations
1
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Agobrim 0,15 % w/v eye drops

Each Vial contains: Brimonidine Tartrate 0,15 % w/v

0.15% w/vEye drops57037857/15.4/0378Approved 15 July 2025RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Brimonidine tartrate

  • S3: Brimonidine

    Consolidated Schedules 06 July 2026, line 3233

Pharmacological class: Others. (class 15.4)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C11H10BrN5292.13 g/mol

5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

Drag to rotate. Structure from PubChem CID 2435.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles